Streetbeat News

Price Targets

ENLV

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on Enlivex Therapeutics (NASDAQ:ENLV) and maintained a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:21 am

RARE

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) and maintained a price target of $82.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:21 am

CBAY

HC Wainwright & Co. analyst Ed Arce maintains a 'Buy' rating on CymaBay Therapeutics (NASDAQ:CBAY) and raises the price target from $12 to $19.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:20 am

TYRA

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a 'Buy' rating on Tyra Biosciences (NASDAQ:TYRA) and maintained a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:19 am

REPL

HC Wainwright & Co. analyst Robert Burns has reiterated a 'Buy' rating on Replimune Group (NASDAQ:REPL) and maintained a price target of $51.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:19 am

BMEA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Biomea Fusion (NASDAQ:BMEA) and maintained a $50 price target.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:18 am

OPT

HC Wainwright & Co. analyst Matthew Caufield has reiterated a 'Buy' rating on Opthea (NASDAQ:OPT) and maintained a $14 price target.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:17 am

ANNX

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Annexon (NASDAQ:ANNX) and maintained a price target of $24.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:17 am

TRNS

HC Wainwright & Co. analyst Scott Buck has reiterated a 'Buy' rating on Transcat (NASDAQ:TRNS) and maintained a price target of $102.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:16 am

UEC

HC Wainwright & Co. analyst Heiko Ihle has reiterated a 'Buy' rating on Uranium Energy (AMEX:UEC) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 10:15 am